Academic Journal
Peritoneal Carcinomatosis: Current State of the Art and Schools of Thought ; Перитонеальный канцероматоз: мировые научные школы и современное состояние вопроса
| Title: | Peritoneal Carcinomatosis: Current State of the Art and Schools of Thought ; Перитонеальный канцероматоз: мировые научные школы и современное состояние вопроса |
|---|---|
| Authors: | Sh. Kh. Gantsev, M. V. Zabelin, K. Sh. Gantsev, A. A. Izmailov, Sh. R. Kzyrgalin, Ш. Х. Ганцев, М. В. Забелин, К. Ш. Ганцев, А. А. Измайлов, Ш. Р. Кзыргалин |
| Source: | Creative surgery and oncology; Том 11, № 1 (2021); 85-91 ; Креативная хирургия и онкология; Том 11, № 1 (2021); 85-91 ; 2076-3093 ; 2307-0501 |
| Publisher Information: | Башкирский государственный медицинский университет |
| Publication Year: | 2021 |
| Collection: | Creative surgery and oncology (E-Journal) / Креативная хирургия и онкология |
| Subject Terms: | научные школы, cytoreductive surgery, systemic chemotherapy, hyperthermic intraperitoneal chemotherapy, school of thought, циторедуктивная хирургия, системная химиотерапия, гипертермическая внутрибрюшинная химиотерапия |
| Description: | Peritoneal carcinomatosis (PC) is a global challenge of modern oncology representing the most unfavourable scenario in diverse-locality tumourisation. Despite certain attention by the oncological community, the management of PC patients is currently palliative, which weakly promotes research into the basic principles of this morbidity. This literature review attempts to comprehensively cover the PC problematic from a global perspective and presents a key evidence on the world schools of thought in this area. Briefly taking, peritoneal carcinomatosis is viewed today as a local process in the conventional implantation theory, which imposes a locoregional character on all current or emerging therapies, such as cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Their inadequate efficacy is largely due to pronounced gaps in our understanding of PC logistics and signalling. PSOGI is a key organisation for centralising the specialty effort in peritoneal carcinomatosis. Despite its global geography and approach to PC discussion, a multitude of scientific questions remain unanswered impeding the establishment of novel effective therapies. The seven countries that nurtured distinguished schools of thought in PC studies are the USA, UK, Japan, China, Italy, France and Germany. Taking peritoneal carcinomatosis in a global perspective, an insufficient attention to its problematic in Russia should be addressed. The founding and fostering of national PC institutions will benefit cancer patients and progress in oncological science. ; Перитонеальный канцероматоз (ПК) является глобальной проблемой современной онкологии, одним из наиболее неблагоприятных вариантов прогрессирования злокачественных опухолей различных локализаций. Несмотря на определенное внимание у онкологического сообщества к теме, в настоящее время лечение пациентов с явлениями ПК больше рассматривается в рамках только паллиативной помощи, что, в свою очередь, не дает достаточного импульса для изучения фундаментальных основ данного процесса. В ... |
| Document Type: | article in journal/newspaper |
| File Description: | application/pdf |
| Language: | Russian |
| Relation: | https://www.surgonco.ru/jour/article/view/575/442; Ганцев Ш.Х., Соломенный С.В., Ганцев К.Ш., Кзыргалин Ш.Р., Минигазимов Р.С., Логинова М.В. Оценка состояния серознолимфатических люков при перитонеальном канцероматозе по данным сканирующей электронной микроскопии (на примере диафрагмальной брюшины). Креативная хирургия и онкология. 2014;(4):4–10. DOI:10.24060/2076-3093-2014-0-4-4-10; Sugarbaker P.H., Yonemura Y. Clinical pathway for the management of resectable gastric cancer with peritoneal seeding: best palliation with a ray of hope for cure. Oncology. 2000;58(2):96–107. DOI:10.1159/000012086; Cotte E., Passot G., Gilly F.N., Glehen O. Selection of patients and staging of peritoneal surface malignancies. World J Gastrointest Oncol. 2010;2(1):31–5. DOI:10.4251/wjgo.v2.i1.31; Sadeghi B., Arvieux C., Glehen O., Beaujard A.C., Rivoire M., Baulieux J., et al. Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer. 2000;88(2):358–63. DOI:10.1002/(sici)1097-0142(20000115)88:23.0.co;2-o; European School of Peritoneal Surface Oncology (ESPSO). [cited 2020 Dec 20]. Available from: http://www.essoweb.org/school-of-peritonealsurface-oncology-es/; Sugarbaker P.H., Chang D., Koslowe P. Prognostic features for peritoneal carcinomatosis in colorectal and appendiceal cancer patients when treated by cytoreductive surgery and intraperitoneal chemotherapy. Cancer Treat Res. 1996;81:89–104. DOI:10.1007/978-1-4613-1245-1_9; Sugarbaker P.H., Stuart O.A. Unusually favorable outcome of 6 consecutive patients with diffuse malignant peritoneal mesothelioma treated with repeated doses of intraperitoneal paclitaxel. A case series. Surg Oncol. 2020;33:96–9. DOI:10.1016/j.suronc.2020.01.009; Sugarbaker P.H. Intraperitoneal delivery of chemotherapeutic agents for the treatment ofperitoneal metastases: current challenges and how to overcome them. Expert Opin Drug Deliv. 2019;16(12):1393–401. DOI:10.1080/17425247.2019.1693997; Carr N.J., Bibeau F., Bradley R.F., Dartigues P., Feakins R.M., Geisinger K.R., et al. The histopathological classification, diagnosis and differential diagnosis of mucinous appendiceal neoplasms, appendiceal adenocarcinomas and pseudomyxoma peritonei. Histopathology. 2017;71(6):847–58. DOI:10.1111/his.13324; Nors J., Funder J.A., Swain D.R., Verwaal V.J., Cecil T., Laurberg S., et al. Postoperative paralytic ileus after cytoreductive surgery combined with heated intraperitoneal chemotherapy. Pleura Peritoneum. 2019;5(1):20190026. DOI:10.1515/pp-2019-0026; Farquharson M., Hollingshead J., Brendan M. (eds). Farquharson’s Textbook of Operative General Surgery. 10th ed. CRC Press; 2014.; Brendan M., Heald R.J. (editors) Manual of Total Mesorectal Excision. CRC Press; 2013.; Canbay E., Yonemura Y. Peritoneal Surface Malignancies: A Curative Approach. 10th ed. Springer; 2015.; Ji Z.H., Peng K.W., Yu Y., Li X.B., Yonemura Y., Liu Y., et al. Current status and future prospects of clinical trials on CRS+HIPEC for gastric cancer peritoneal metastases. Int J Hyperthermia. 2017;33(5):562–70. DOI:10.1080/02656736.2017.1283065; Coccolini F., Nardi M., Montori G., Ceresoli M., Celotti A., Cascinu S., et al. Neoadjuvant chemotherapyin advanced gastric and esophago-gastric cancer. Meta-analysis of randomized trials. Int J Surg. 2018;51:120–7. DOI:10.1016/j.ijsu.2018.01.008; Lin Y.L., Zhang J., Yan F.C., Jiang X., Ma R., Yang Z.R., et al. Establishment of patient-derived xenograft model of peritoneal mucinous carcinomatosis with signet ring cells and in vivo study on the efficacy and toxicity of intraperitoneal injection of 5-fluorouracil. Cancer Med. 2020;9(3):1104–14. DOI:10.1002/cam4.2766; Yang X.J., Huang C.Q., Suo T., Mei L.J., Yang GL., Cheng F.L., et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial. Ann Surg Oncol. 2011;18(6):1575–81. DOI:10.1245/s10434-011-1631-5; Huang C.Q., Min Y., Wang S.Y., Yang X.J., Liu Y., Xiong B., et al. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival for peritoneal carcinomatosis from colorectal cancer: a systematic review and meta-analysis of currentevidence. Oncotarget. 2017;8(33):55657–83. DOI:10.18632/oncotarget.17497; Guadagni S., Clementi M., Masedu F., Fiorentini G., Sarti D., Deraco M., et al. A pilot study of the predictive potential of chemosensitivity and gene expression assays using circulating tumour cells from patients with recurrent ovarian cancer. Int J Mol Sci. 2020;21(13):4813. DOI:10.3390/ijms21134813; Belfiore A., Busico A., Bozzi F., Brich S., Dallera E., Conca E., et al. Molecular signatures for combined targeted treatments in diffuse malignant peritoneal mesothelioma. Int J Mol Sci. 2019;20(22):5817. DOI:10.3390/ijms20225817; Glehen O., Gilly F.N. Quantitative prognostic indicators of peritoneal surface malignancy: carcinomatosis, sarcomatosis, and peritoneal mesothelioma. Surg Oncol Clin N Am. 2003;12(3):649–71. DOI:10.1016/s1055-3207(03)00037-1; Alyami M., Hübner M., Grass F., Bakrin N., Villeneuve L., Laplace N., et al. Pressurised intraperitoneal aerosol chemotherapy: rationale, evidence, and potential indications. Lancet Oncol. 2019;20(7):e368–77. DOI:10.1016/S1470-2045(19)30318-3; Glehen O., Osinsky D., Beaujard A.C., Gilly F.N. Natural history of peritoneal carcinomatosis from non gynecologic malignancies. Surg Oncol Clin N Am. 2003;12(3):729–39, XIII. DOI:10.1016/s1055-3207(03)00044-9; Glehen O., Gilly F.N., Cotte E. Hyperthermic intraperitoneal chemotherapy in advanced gastric cancer: the end of skepticism? Ann Surg Oncol. 2011;18(6):1524–6. DOI:10.1245/s10434-011-1632-4; Rau B., Brandl A., Piso P., Pelz J., Busch P., Demtröder C., et al. Peritoneal metastasis in gastric cancer: results from the German database. Gastric Cancer. 2020;23(1):11–22. DOI:10.1007/s10120-019-00978-0; Vassos N., Piso P. Metastatic colorectal cancer to the peritoneum: current treatment options. Curr Treat Options Oncol. 2018;19(10):49. DOI:10.1007/s11864-018-0563-8; https://www.surgonco.ru/jour/article/view/575 |
| DOI: | 10.24060/2076-3093-2021-11-1-85-91 |
| Availability: | https://www.surgonco.ru/jour/article/view/575 https://doi.org/10.24060/2076-3093-2021-11-1-85-91 |
| Rights: | Authors who publish with this journal agree to the following terms:Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access). ; Авторы, публикующие статью в данном журнале, соглашаются со следующим:Авторы сохраняют за собой авторские права на работу и предоставляют журналу право первой публикации работы на условиях лицензии Creative Commons Attribution License, которая позволяет другим распространять данную работу с обязательным сохранением ссылок на авторов оригинальной работы и оригинальную публикацию в этом журнале.Авторы сохраняют право заключать отдельные контрактные договорённости, касающиеся не-эксклюзивного распространения версии работы в опубликованном здесь виде (например, размещение ее в институтском хранилище, публикацию в книге), со ссылкой на ее оригинальную публикацию в этом журнале.Авторы имеют право размещать их работу в сети Интернет (например в институтском хранилище или персональном сайте) до и во время процесса рассмотрения ее данным журналом, так как это может привести к продуктивному обсуждению и большему количеству ссылок на данную работу (См. The Effect of Open Access). |
| Accession Number: | edsbas.155BAEE4 |
| Database: | BASE |
| DOI: | 10.24060/2076-3093-2021-11-1-85-91 |
|---|